Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact

Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact

The aim of this study was to evaluate the prevalence, the clinicopathological variables associated with probability of lung metastases, and the impact of lung metastases on survival outcome in patients with stage IV pancreatic cancer (PC) treated with palliative chemotherapy. A total of 654 patients...

Full description

Bibliographic Details
Main Authors: Keng-Hao Liu, Chia-Yen Hung, Shu-Wen Hsueh, Pei-Hung Chang, Yen-Yang Chen, Chang-Hsien Lu, Ping-Tsung Chen, Kun-Yun Yeh, Pei-Wei Huang, Ngan-Ming Tsang, Yu-Shin Hung, Wen-Chi Chou
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Journal of Clinical Medicine
Subjects:
pancreatic cancer
lung metastases
incidence
risk factor
outcome
palliative chemotherapy
Online Access:https://www.mdpi.com/2077-0383/8/9/1402

Internet

https://www.mdpi.com/2077-0383/8/9/1402

Similar Items